Dr. Jorge Sarroca has 34 years of experience working for the Pharmaceutical Industry. He started his career in 1986 founding Medisys, the first CRO in Spain, from which he expanded to one of Europe’s first CRO Alliances with The Gabbay Group, and finally was PPD as Spain’s Country Manager. In total he participated in over 250 clinical studies in this 15 years period, acquiring very sound knowledge of design, analysis and publication of clinical research. He then moved strategically to Medical Affairs, working for Pfizer, Esteve-Teijin, Alexion and Almirall, where is Senior Medical Advisor working in three different therapeutic areas.
He served as Member of the Board at AMIFE, the Spanish Association of Pharmaceutical Physicians for 3 4-year periods. Very interested in Education, he is Associate Professor at the Pompeu Fabra University and collaborates with the European University and the IEBS school.
Passionate for innovation and patient-centricity, along his career there have been some relevant milestones, like founding the first CRO in Spain, changing the patient care model in Home Respiratory Therapies, filing an NDA application for a medicinal gas (xenon for neuroprotection), co-chairing a 15MM project for home
rehabilitation, developing a structured method for drugs life-cycle management and, very recently, changing the paradigm for the treatment of multiple sclerosis spasticity.